Article PDF
Avoid common mistakes on your manuscript.
References
Batlle, E., Henderson, J.T., Beghtel, H., van den Born, M.M., Sancho, E., Huls, G., Meeldijk, J., Robertson, J., van de Wetering, M., Pawson, T., et al. (2002). Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111, 251–263.
Cortina, C., Palomo-Ponce, S., Iglesias, M., Fernández-Masip, J.L., Vivancos, A., Whissell, G., Humà, M., Peiró, N., Gallego, L., Jonkheer, S., et al. (2007). EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat Genet 39, 1376–1383.
Kosinski, C., Li, V.S., Chan, A.S., Zhang, J., Ho, C., Tsui, W.Y., Chan, T.L., Mifflin, R.C., Powell, D.W., Yuen, S.T., et al. (2007). Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci U S A 104, 15418–15423.
Merlos-Suárez, A., Barriga, F.M., Jung, P., Iglesias, M., Céspedes, M. V., Rossell, D., Sevillano, M., Hernando-Momblona, X., da Silva-Diz, V., Muñoz, P., et al. (2011). The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8, 511–524.
Rights and permissions
About this article
Cite this article
Zhang, X. EphB2: a signature of colorectal cancer stem cells to predict relapse. Protein Cell 2, 347–348 (2011). https://doi.org/10.1007/s13238-011-1058-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13238-011-1058-6